RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      병기 T1, 분화도 3 방광암에 있어서 Cyclooxygenase-2와 p53의 예후 판정의 가치 = Prognostic Value of Cyclooxygenase-2 and p53 Expression in Stage T1 Grade III Bladder Cancer

      한글로보기

      https://www.riss.kr/link?id=A104587707

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Purpose: The prognostic value of p53 remains controversial in stage T1, grade III(T1GIII) transitional cell carcinomas(TCC) of the bladder. Recent studies have reported increased expression of cyclooxygenase-2(COX-2) in bladder cancer. The prognostic ...

      Purpose: The prognostic value of p53 remains controversial in stage T1, grade III(T1GIII) transitional cell carcinomas(TCC) of the bladder. Recent studies have reported increased expression of cyclooxygenase-2(COX-2) in bladder cancer. The prognostic values of p53 and COX-2 were compared in T1GIII TCC of the bladder.
      Materials and Methods: Among 57 consecutive patients, diagnosed with T1GIII TCC of the bladder by transurethral resection(TURB), 37 were eligible for this study. Exclusion criteria included; the first TURB performed elsewhere, no or inadequate(less than 6 weeks) bacillus Calmette- Guerin treatment and postoperative follow-up of less than 1 year. The expressions of p53 and COX-2 were evaluated by immunohistochemical staining of TURB tissues. Possible correlations of the p53 and COX-2 expressions with the clinicopathological features, such as age, shape and multiplicity of tumor, recurrence and progression, were examined.
      Results: During a mean follow-up of 27 months, the disease recurred in 43.2% and progressed in 16.2%. Of the 37 specimens, 31(83.8%) and 16(43.2%) stained positive for COX-2 and p53 expressions, respectively. There were no significant differences in age, shape and multiplicity of the tumors, recurrence-free survival and progression-free survival between the p53 positive and negative groups. However, the recurrence-free and progression-free survivals were significantly lower in the COX-2 positive than in the COX-2 negative group(p=0.049 and p=0.027, respectively). When combined, p53 and COX-2 more accurately predicted recurrence than COX-2 alone(p=0.036), but not the progression(p=0.776).
      Conclusions: In the pathologically homogeneous group of T1GIII TCC of the bladder, COX-2 was superior to p53 in predicting the prognosis.

      더보기

      참고문헌 (Reference)

      1 "p53-mediated induction of Cox-2 counteracts p53- or genotoxic stress induced apoptosis" 21 : 5635-5644, 2002

      2 "p53 status does not predict initial clinical response to bacillus Calmette-Guerin intravesical therapy in T1 bladder tumors" 159 : 1079-1084, 1998

      3 "p53 immunoreactivity in biopsy specimens of T1G3 transitional cell carcinoma of the bladder - a helpful parameter in guiding the decision for or against cystectomy?" 36 : 610-614, 2000

      4 "Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder" 92 : 188-193, 2001

      5 "Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients" 71-7, surgery1984

      6 "Prognostic value of p53 overexpression in T1G3 bladder tumors treated with bacillus Calmette-Guerin therapy" 59 : 409-413, 2002

      7 "Predictive value of cell cycle markers p53 and Ki-67 in superficial bladder tumor recurrence" 5 : 4079-4084, 1999

      8 "Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guerin therapy correlation to clinical outcome" 14 : 2646-2652, 1996

      9 "Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ" 575-80, jurol1976

      10 "Immunohistological expression of p53 in primary pT1 transitional cell bladder cancer in relation to tumour progression" 526-32, brjurol1994

      1 "p53-mediated induction of Cox-2 counteracts p53- or genotoxic stress induced apoptosis" 21 : 5635-5644, 2002

      2 "p53 status does not predict initial clinical response to bacillus Calmette-Guerin intravesical therapy in T1 bladder tumors" 159 : 1079-1084, 1998

      3 "p53 immunoreactivity in biopsy specimens of T1G3 transitional cell carcinoma of the bladder - a helpful parameter in guiding the decision for or against cystectomy?" 36 : 610-614, 2000

      4 "Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder" 92 : 188-193, 2001

      5 "Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients" 71-7, surgery1984

      6 "Prognostic value of p53 overexpression in T1G3 bladder tumors treated with bacillus Calmette-Guerin therapy" 59 : 409-413, 2002

      7 "Predictive value of cell cycle markers p53 and Ki-67 in superficial bladder tumor recurrence" 5 : 4079-4084, 1999

      8 "Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guerin therapy correlation to clinical outcome" 14 : 2646-2652, 1996

      9 "Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ" 575-80, jurol1976

      10 "Immunohistological expression of p53 in primary pT1 transitional cell bladder cancer in relation to tumour progression" 526-32, brjurol1994

      11 "Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder" 78 : 1762-1774, 1996

      12 "Host cyclooxygenase-2 modulates carcinoma growth." 105 : 1589-1594, 2000

      13 "Expression of cyclooxygenase-2(COX-2) in human invasive transitional cell carcinoma(TCC) of the urinary bladder" 59 : 5647-5650, 1999

      14 "Expression of cyclooxygenase-2 in patients with bladder carcinoma" 165 : 1468-1472, 2001

      15 "Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder" 158 : 849-853, 2001

      16 "Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas" 157 : 29-35, 2000

      17 "Cyclooxygenase regulates angiogenesis induced by colon cancer cells" 93 : 705-716, 1998

      18 "Correlation between p53 over expression and response to bacillus Calmette-Guerin therapy in a high risk select population of patients with T1G3 bladder cancer" 159 : 788-791, 1998

      19 "Correlation and prognostic significance of p53 p21WAF1/CIP1 and Ki-67 expression in patients with super-ficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy" 161 : 792-798, 1999

      20 "Can p53 nuclear over-expression, Bcl-2 accumulation and PCNA status be of prognostic significance in high-risk superficial and invasive bladder tumours?" 25 : 61-65, 1999

      21 "Can biological markers predict recurrence and progression of superficial bladder cancer" 10 : 441-445, 2000

      22 "Association of p53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder" 388-92, jurol1994

      23 "Association of cyclooxygenase-2 expression with prognosis of stage T1 grade 3 bladder cancer" 60 : 816-821, 2002

      24 "Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2" 83 : 493-501, 1995

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2019-03-12 학회명변경 한글명 : 대한비뇨기과학회 -> 대한비뇨의학회 KCI등재
      2016-03-04 학술지명변경 외국어명 : 미등록 -> Investigative and Clinical Urology KCI등재
      2016-01-15 학술지명변경 한글명 : Korean Journal of Urology -> Investigative and Clinical Urology KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-02-21 학술지명변경 한글명 : 대한비뇨기과학회지 -> Korean Journal of Urology
      외국어명 : The Korean Journal of Urology -> 미등록
      KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.14 0.14 0.13
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.13 0.12 0.314 0.23
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼